Skip to main content
Joel Emanuel Sohlin on Muck Rack

Joel Emanuel Sohlin

As seen in: BMJ Oncology
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Joel Emanuel

Contact Joel Emanuel, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Identification of protein biomarker candidates associated with organ-specific immune-related toxicity and response to management by plasma proteomics

|
By Ole Østergaard, Inge Mansfield Noringriis, Anders Handrup Kverneland, Joel Emanuel Sohlin
| BMJ Oncology Verified
Bloodborne biomarkers are routinely used to diagnose immune-related adverse events (irAEs) in a tissue-specific approach, but for many tissues, no biomarkers are available. Management is, as first line, a one-size-fits-all with corticosteroids, while second line is tissue-specific based on experiences in autoimmune disorders. Patient stratification for management is currently not performed.
Open in Who Shared Issue with article?
See all 1 articles